1-20 of 5,074 results for subject:Diabetes
Librarians' tools
- Search time
- 0.277 seconds
- Solr query time
- 0.011 seconds
- Search query
- subject:Diabetes
- We searched for
- subject_t:Diabetes OR subject_ses:9636
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to raise awareness of diabetes distress amongst professionals working in NHS Mental Health Support Teams in schools.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to raise awareness of diabetes distress amongst professionals working in NHS Mental Health Support Teams in schools.
To ask the Secretary of State for Education, what steps her Department is taking with the Department of Health and Social Care to raise awareness of diabetes distress amongst pastoral staff in schools.
To ask the Secretary of State for Education, what steps her Department is taking with the Department of Health and Social Care to raise awareness of diabetes distress amongst pastoral staff in schools.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure psychologists are embedded in NHS diabetes multidisciplinary teams in England.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure psychologists are embedded in NHS diabetes multidisciplinary teams in England.
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of NHS mental health support for diabetes distress in England.
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of NHS mental health support for diabetes distress in England.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to raise awareness of diabetes distress amongst mental health professionals working in NHS Talking Therapies.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to raise awareness of diabetes distress amongst mental health professionals working in NHS Talking Therapies.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the availability of training for GPs on recognising and managing type 1 diabetes in infants.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the availability of training for GPs on recognising and managing type 1 diabetes in infants.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that all Integrated Care Boards have access to multidisciplinary specialist foot-care teams for people with diabetes.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that all Integrated Care Boards have access to multidisciplinary specialist foot-care teams for people with diabetes.
As per the link below, there is extensive information on the main National Health Service website concerning Peripheral neuropathy and other diabetes-related foot complications:
https://www.nhs.uk/conditions/peripheral-neuropathy/
Integrated care boards (ICBs) are responsible for commissioning services to meet the needs of their local populations, including for foot-related diabetes conditions, and must ensure patients facing those conditions can access high-quality care and treatment.
NHS England maintains a dashboard enabling all services in England and Wales that treat people with diabetes related foot disease to measure their performance against the National Institute for Health and Care Excellence (NICE) guidance for prevention and management of diabetic foot problems, to monitor patient outcomes, and to benchmark against peer units. The dashboard can be found at the following link:
In addition, the NICE guidance found at the following link:
To ask the Secretary of State for Health and Social Care, what steps the department is taking to reduce the incidence of diabetes-related lower-limb amputations, including by improving early detection of peripheral neuropathy and access to preventative foot-care services.
To ask the Secretary of State for Health and Social Care, what steps the department is taking to reduce the incidence of diabetes-related lower-limb amputations, including by improving early detection of peripheral neuropathy and access to preventative foot-care services.
As per the link below, there is extensive information on the main National Health Service website concerning Peripheral neuropathy and other diabetes-related foot complications:
https://www.nhs.uk/conditions/peripheral-neuropathy/
Integrated care boards (ICBs) are responsible for commissioning services to meet the needs of their local populations, including for foot-related diabetes conditions, and must ensure patients facing those conditions can access high-quality care and treatment.
NHS England maintains a dashboard enabling all services in England and Wales that treat people with diabetes related foot disease to measure their performance against the National Institute for Health and Care Excellence (NICE) guidance for prevention and management of diabetic foot problems, to monitor patient outcomes, and to benchmark against peer units. The dashboard can be found at the following link:
In addition, the NICE guidance found at the following link:
To ask the Secretary of State for Health and Social Care, what plans the department has to improve public awareness of peripheral neuropathy and early signs of diabetes-related foot complications.
To ask the Secretary of State for Health and Social Care, what plans the department has to improve public awareness of peripheral neuropathy and early signs of diabetes-related foot complications.
As per the link below, there is extensive information on the main National Health Service website concerning Peripheral neuropathy and other diabetes-related foot complications:
https://www.nhs.uk/conditions/peripheral-neuropathy/
Integrated care boards (ICBs) are responsible for commissioning services to meet the needs of their local populations, including for foot-related diabetes conditions, and must ensure patients facing those conditions can access high-quality care and treatment.
NHS England maintains a dashboard enabling all services in England and Wales that treat people with diabetes related foot disease to measure their performance against the National Institute for Health and Care Excellence (NICE) guidance for prevention and management of diabetic foot problems, to monitor patient outcomes, and to benchmark against peer units. The dashboard can be found at the following link:
In addition, the NICE guidance found at the following link:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to increase localised preventive care and diagnostic capacity in parliamentary constituencies where UK Health Security Agency profile data indicates Type 2 diabetes prevalence exceeds 12 per cent, such as Leicester East.
To ask the Secretary of State for Health and Social Care, what steps her department is taking to increase localised preventive care and diagnostic capacity in parliamentary constituencies where UK Health Security Agency profile data indicates Type 2 diabetes prevalence exceeds 12 per cent, such as Leicester East.
NHS England commissions the Healthier You NHS Diabetes Prevention Programme available to all integrated care boards (ICBs) in England. For eligible people with recently diagnosed type 2 diabetes, NHS England commissions the NHS Type 2 Diabetes Path to Remission Programme, which is also available to all ICBs in England.
Together, these national programmes complement locally commissioned prevention, weight management and diabetes care services, helping to address the high prevalence of type 2 diabetes by preventing or delaying new cases.
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical research facilities (CRFs), and its Research Delivery Network (RDN). Through this infrastructure:
- the NIHR RDN is supporting the delivery of the Early Surveillance for Autoimmune Diabetes study, which is assessing the feasibility and benefits of screening children and young people for type 1 diabetes;
- the NIHR Oxford BRC is leading research into a new home test for type 1 diabetes in children and young people, exploring whether at-home testing could be employed more routinely across the National Health Service;
- the NIHR is supporting a UK-wide Type 1 Diabetes Cell Therapy Clinical Trials Network, a £5 million programme designed to build a nationwide infrastructure across NIHR BRCs and CRFs to support cell-therapy trials, enabling people with type 1 diabetes to gain access to the latest cutting-edge treatments as early as possible; and
- the NIHR is also investing £2.9 million in partnership with Diabetes UK to support the development and evaluation of the ‘D-stress’ programme, in order to identify the most effective way to prevent and treat type 1 diabetes distress, helping to improve the management of the condition, and the quality of life for those living with it.
The NIHR continues to welcome high-quality applications for research into type 1 diabetes, which will be assessed against its normal criteria, and judged in open competition.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support research into the prevention, treatment and management of type 1 diabetes.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support research into the prevention, treatment and management of type 1 diabetes.
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical research facilities (CRFs), and its Research Delivery Network (RDN). Through this infrastructure:
- the NIHR RDN is supporting the delivery of the Early Surveillance for Autoimmune Diabetes study, which is assessing the feasibility and benefits of screening children and young people for type 1 diabetes;
- the NIHR Oxford BRC is leading research into a new home test for type 1 diabetes in children and young people, exploring whether at-home testing could be employed more routinely across the National Health Service;
- the NIHR is supporting a UK-wide Type 1 Diabetes Cell Therapy Clinical Trials Network, a £5 million programme designed to build a nationwide infrastructure across NIHR BRCs and CRFs to support cell-therapy trials, enabling people with type 1 diabetes to gain access to the latest cutting-edge treatments as early as possible; and
- the NIHR is also investing £2.9 million in partnership with Diabetes UK to support the development and evaluation of the ‘D-stress’ programme, in order to identify the most effective way to prevent and treat type 1 diabetes distress, helping to improve the management of the condition, and the quality of life for those living with it.
The NIHR continues to welcome high-quality applications for research into type 1 diabetes, which will be assessed against its normal criteria, and judged in open competition.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the contribution of UK research to improving outcomes for people with type 1 diabetes.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the contribution of UK research to improving outcomes for people with type 1 diabetes.
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical research facilities (CRFs), and its Research Delivery Network (RDN). Through this infrastructure:
- the NIHR RDN is supporting the delivery of the Early Surveillance for Autoimmune Diabetes study, which is assessing the feasibility and benefits of screening children and young people for type 1 diabetes;
- the NIHR Oxford BRC is leading research into a new home test for type 1 diabetes in children and young people, exploring whether at-home testing could be employed more routinely across the National Health Service;
- the NIHR is supporting a UK-wide Type 1 Diabetes Cell Therapy Clinical Trials Network, a £5 million programme designed to build a nationwide infrastructure across NIHR BRCs and CRFs to support cell-therapy trials, enabling people with type 1 diabetes to gain access to the latest cutting-edge treatments as early as possible; and
- the NIHR is also investing £2.9 million in partnership with Diabetes UK to support the development and evaluation of the ‘D-stress’ programme, in order to identify the most effective way to prevent and treat type 1 diabetes distress, helping to improve the management of the condition, and the quality of life for those living with it.
The NIHR continues to welcome high-quality applications for research into type 1 diabetes, which will be assessed against its normal criteria, and judged in open competition.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of earlier diagnosis and preventative technologies, including continuous glucose monitoring, on reducing the economic impact of Type 2 diabetes.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of earlier diagnosis and preventative technologies, including continuous glucose monitoring, on reducing the economic impact of Type 2 diabetes.
The eligibility criteria for continuous glucose monitoring amongst type 2 diabetics are set in guidance published by the National Institute for Health and Care Excellence. This guidance is available at the following link:
https://www.nice.org.uk/guidance/NG28
No assessment has been made, as continuous glucose monitoring devices have not been validated for the use of diagnosis of type 2 diabetes.
The Healthier You NHS Diabetes Prevention Programme, is highly effective in cutting the risk of developing type 2 diabetes by 37% for people completing the programme compared to those who do not attend.
Outcomes for the Type 2 Diabetes Path to Remission Programme demonstrates that 32% of programme completers achieved remission with an average weight loss of almost 16 kilograms.
To ask the Secretary of State for Health and Social Care, whether she has assessed the potential impact of funding preventative interventions for people with pre-diabetes and early Type 2 diabetes on the economy.
To ask the Secretary of State for Health and Social Care, whether she has assessed the potential impact of funding preventative interventions for people with pre-diabetes and early Type 2 diabetes on the economy.
The eligibility criteria for continuous glucose monitoring amongst type 2 diabetics are set in guidance published by the National Institute for Health and Care Excellence. This guidance is available at the following link:
https://www.nice.org.uk/guidance/NG28
No assessment has been made, as continuous glucose monitoring devices have not been validated for the use of diagnosis of type 2 diabetes.
The Healthier You NHS Diabetes Prevention Programme, is highly effective in cutting the risk of developing type 2 diabetes by 37% for people completing the programme compared to those who do not attend.
Outcomes for the Type 2 Diabetes Path to Remission Programme demonstrates that 32% of programme completers achieved remission with an average weight loss of almost 16 kilograms.
Motion that this House has considered the potential merits of reform of the vascular sector. Agreed to question.
Motion that this House has considered the potential merits of reform of the vascular sector. Agreed to question.
I beg to move,
That this House has considered the potential merits of reform of the vascular sector.
It is a real pleasure to serve under your chairship, Dr Huq. Last night, you were in the Adjournment debate, and today you are chairing a Westminster Hall debate. Your talents are incredible—well done...
I beg to move,
That this House has considered the potential merits of reform of the vascular sector.
It is a real pleasure to serve under your chairship, Dr Huq. Last night, you were in the Adjournment debate, and today you are chairing a Westminster Hall debate. Your talents are incredible—well done...
The statistics that the hon. Gentleman highlights should shock us all. If those were the statistics for dealing with any cancer, we would simply find them unacceptable. Does he agree that vascular disease, because it is not treated in the same way as cancer, in some cases ends up being...
The statistics that the hon. Gentleman highlights should shock us all. If those were the statistics for dealing with any cancer, we would simply find them unacceptable. Does he agree that vascular disease, because it is not treated in the same way as cancer, in some cases ends up being...
I thank the hon. Gentleman for that intervention. He has rightly said that, when it comes to vascular disease, while it is equal with cancer in its severity and in the numbers who lose their lives, it is not treated the same. Today’s debate perhaps gives us a chance to...
I thank the hon. Gentleman for that intervention. He has rightly said that, when it comes to vascular disease, while it is equal with cancer in its severity and in the numbers who lose their lives, it is not treated the same. Today’s debate perhaps gives us a chance to...
It is a pleasure to serve under your chairmanship today, Dr Huq. I thank the hon. Member for Strangford (Jim Shannon) for securing this debate.
The publication of the 2026 cardiovascular disease modern service framework is a welcome step towards realising our commitment to a more preventative, community-focused health service. It...
It is a pleasure to serve under your chairmanship today, Dr Huq. I thank the hon. Member for Strangford (Jim Shannon) for securing this debate.
The publication of the 2026 cardiovascular disease modern service framework is a welcome step towards realising our commitment to a more preventative, community-focused health service. It...